MR1 overexpression correlates with poor clinical prognosis in glioma patients.
Kubica P, Lara-Velazquez M, Bam M, Siraj S, Ong I, Liu P, Priya R, Salamat S, Brutkiewicz RR, Dey M.
Kubica P, et al. Among authors: bam m.
Neurooncol Adv. 2021 Feb 20;3(1):vdab034. doi: 10.1093/noajnl/vdab034. eCollection 2021 Jan-Dec.
Neurooncol Adv. 2021.
PMID: 33948562
Free PMC article.